focus -WSS

focus

author：explore 2025-09-29 18:16:38 - browse：46

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The release of Novo Nordisk’s latest earnings report on Thursday provided a chance for executives to tout their major win this week — outcomes from a large trial showing the company’s obesity drug Wegovy cut the risk of heart complications by 20%.

But once again, much of the attention was focused on the company’s struggles to meet what Novo CEO Lars Fruergaard Jørgensen referred to as the “overwhelming demand for Wegovy.”

Jørgensen reiterated that the company was racing to expand supply and had brought on more contract manufacturing support, but Novo said Thursday that the company would continue to restrict the availability of lower-strength starter doses in the United States to ensure that patients on the drug would not have their medication interrupted.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： FDA approves updated Covid vaccines

explore

entertainment

WSS

Make 'food is medicine' a key part of White House nutrition meeting

How to make the FDA’s new prescription one

White House touts steps to stem shortages of cancer treatments

Bacterial infection may be ‘key event’ in endometriosis, study says

Can food be medicine? And other questions about a new push

Make 'food is medicine' a key part of White House nutrition meeting

explore

focus

explore

Bright Health sells Medicare Advantage business to Molina

Can food be medicine? And other questions about a new push

Continuity nursing helped my family in our darkest PICU moments

These geoengineering technologies could help combat the climate crisis, scientists say

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

WATCH: Why do bright lights make us see spots?

Novavax promises a turnaround & Lilly roils the obesity market

Walmart eyes Medicare Advantage provider ChenMed

Dobbs anniversary: the lost opportunity of abortion as health care

Brain 'hot spot' may explain why African Americans feel greater pain

hotspot

Diverse clinical trials: Why aren’t we there yet?

FDA approves updated Covid vaccines

How housing is health care on Long Island

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Walmart eyes Medicare Advantage provider ChenMed

New weight loss drugs vying to be the next Wegovy or Mounjaro

knowledge

explore

entertainment

entertainment